| Assessment of laboratory assays to measure rivaroxaban–an oral, direct factor Xa inhibitor MM Samama, JL Martinoli, L LeFlem, C Guinet, G Plu-Bureau, F Depasse, ... Thrombosis and haemostasis 103 (04), 815-825, 2010 | 575 | 2010 |
| In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban GT Gerotziafas, I Elalamy, F Depasse, E Perzborn, MM Samama Journal of Thrombosis and Haemostasis 5 (4), 886-888, 2007 | 200 | 2007 |
| Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram … GT Gerotziafas, F Depasse, J Busson, L Leflem, I Elalamy, MM Samama Thrombosis journal 3, 1-11, 2005 | 184 | 2005 |
| An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma MM Samama, J Amiral, C Guinet, E Perzborn, F Depasse Thrombosis and haemostasis 104 (11), 1078-1079, 2010 | 147 | 2010 |
| Factor VII deficiency: from basics to clinical laboratory diagnosis and patient management PO Sevenet, DA Kaczor, F Depasse Clinical and applied thrombosis/hemostasis 23 (7), 703-710, 2017 | 92 | 2017 |
| Effect of BAY 59-7939-a novel, oral, direct factor Xa inhibitor-on clot-bound factor Xa activity in vitro F Depasse, J Busson, J Mnich, L Le Flem, GT Gerotziafas, MM Samama J Thromb Haemost 3 (Suppl 1), P1104, 2005 | 87 | 2005 |
| Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood GT Gerotziafas, F Depasse, T Chakroun, MM Samama, I Elalamy Thrombosis and haemostasis 91 (03), 531-537, 2004 | 73 | 2004 |
| Clinical use of thrombin generation assays TPL Binder NB, Depasse F, Mueller J, Wissel T, Schwers S, Germer M, Hermes B J Thromb Haemost, 2021 | 65 | 2021 |
| The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation GT Gerotziafas, T Chakroun, F Depasse, P Arzoglou, MM Samama, ... Thrombosis and haemostasis 91 (05), 977-985, 2004 | 64 | 2004 |
| Proteomics of methylene blue photo‐treated plasma before and after removal of the dye by an absorbent filter D Crettaz, L Sensebe, DH Vu, P Schneider, F Depasse, WV Bienvenut, ... Proteomics 4 (3), 881-891, 2004 | 59 | 2004 |
| Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalisation with an external reference plasma J Perrin, F Depasse, T Lecompte, APHP BEAUJON, E De Raucourt, ... Thrombosis research 136 (1), 125-130, 2015 | 57 | 2015 |
| Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma GT Gerotziafas, F Depasse, T Chakroun, P Van Dreden, MM Samama, ... Blood coagulation & fibrinolysis 15 (2), 149-156, 2004 | 55 | 2004 |
| Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra®) anti‐Xa activity F Depasse, GT Gerotziafas, J Busson, P Van Dreden, MM Samama Journal of Thrombosis and Haemostasis 2 (2), 346-379, 2004 | 54 | 2004 |
| Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine F Depasse, NB Binder, J Mueller, T Wissel, S Schwers, M Germer, ... Journal of Thrombosis and Haemostasis 19 (12), 2907-2917, 2021 | 51 | 2021 |
| Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants MM Samama, L Le Flem, C Guinet, G Gerotziafas, F Depasse Journal of Thrombosis and Haemostasis 5 (12), 2554-2556, 2007 | 51 | 2007 |
| Clot waveform analysis: where do we stand in 2017? PO Sevenet, F Depasse International journal of laboratory hematology 39 (6), 561-568, 2017 | 47 | 2017 |
| Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637 J Deinum, C Mattsson, T Inghardt, M Elg Thrombosis and haemostasis 101 (06), 1051-1059, 2009 | 47 | 2009 |
| The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerisation indices F Depasse, L Sensebé, J Seghatchian, G Andreu, MM Samama Transfusion and apheresis science 33 (1), 63-69, 2005 | 47 | 2005 |
| Comparative study of the pharmacokinetic profiles of two LMWHs—bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)—administered subcutaneously to healthy male … F Depasse, MJG de Suso, I Lagoutte, J Fontcuberta, M Borrell, ... Thrombosis research 109 (2-3), 109-117, 2003 | 47 | 2003 |
| Factor Xa inhibitors E Perzborn Hämostaseologie 29 (03), 260-267, 2009 | 45 | 2009 |
